Pulmocide Stock

Pulmocide is focused on the development of inhaled medicines for the treatment of viral and fungal infections of the respiratory tract.

Sign up today and learn more about Pulmocide Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Pulmocide Stock

Pulmocide Ltd, a company focused on the discovery and development of a new generation of inhaled medicines for the treatment of serious viral and fungal infections of the respiratory tract.

Funding History

November 2013$17.0M
March 2017$30.4M
May 2021$92.0M
December 2021$3.5M
December 2022$52.0M

Management

Board Member

Kate Bingham

Chairman and Chief Executive Officer

Dan Burgess

Chief Business Officer

Jennifer Cayer

Board Member

Sabine Dandiguian

Member Board Of Directors

Jeanne Bolger

Board Director

Matthew Foy

CSO

Pete Strong

Board Member

Kabeer Aziz

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo